#multiple sclerosis

All articles tagged with "multiple sclerosis"

Researchers found large numbers of fat-laden microglia in rapidly progressing MS tissue.
Patients with more foamy microglia more often had severe disease courses.
The work points to possible biomarkers and future treatment targets.

DT Editorial Team·May 22, 2026·via medicalxpress.com

Researchers studied 617,186 people to probe how EBV may contribute to MS.
The virus appears to manipulate B-cells and activate genes tied to disease risk.
The findings strengthen the shift from correlation toward mechanism in EBV-MS research.

DT Editorial Team·Apr 24, 2026·via newscientist.com

Roche’s oral MS candidate more than doubled relapse-free interval versus Aubagio, according to conference data.
The drug is described as a BTK inhibitor, a class under close watch in neuroinflammatory disease.
Potential liver toxicity could shape how regulators and clinicians evaluate the treatment.

DT Editorial Team·Apr 22, 2026·via endpoints.news

MS prevalence in England more than doubled from 2000 to 2020, growing at approximately 6% per year
The increase primarily reflects better MRI-based diagnosis and longer patient survival rather than increased incidence
Disease-modifying therapies have substantially reduced excess mortality associated with MS over the study period
Treatment advances have been less effective for progressive MS than for relapsing forms, leaving a persistent care gap
Growing prevalence has significant implications for NHS capacity planning and high-cost therapy budgets

DT Editorial Team·Mar 24, 2026·via medicalxpress.com